Saori Fukuda

Dr. Saori Fukuda

Virology, Fujita Health University, Toyoake, Aichi, Japan
+1
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
SKSatoshi Komoto
Satoshi Komoto
Saori FukudaSaori Fukuda
Saori Fukuda
TITomihiko Ide
Tomihiko Ide
NINaoto Ito
Naoto Ito
MSMakoto Sugiyama
Makoto Sugiyama
KTKoki Taniguchi
Koki Taniguchi
An entirely plasmid-based reverse genetics system for rotaviruses was established very recently. We improved the reverse genetics system to generate recombinant rotavirus by transfecting only 11 cDNA plasmids for its 11 gene segments under the condition of increasing the ratio of the cDNA plasmids for NSP2 and NSP5 genes. Utilizing this highly efficient system, we then engineered infectious recombinant rotaviruses expressing bioluminescent (NanoLuc luciferase) and fluorescent (enhanced green fluorescent protein [EGFP] and mCherry) reporters. These recombinant rotaviruses expressing reporters remained genetically stable during serial passages. Our reverse genetics approach and recombinant rotaviruses carrying reporter genes will be great additions to the tool kit for studying the molecular virology of rotavirus and for developing future next-generation vaccines and expression vectors.IMPORTANCERotavirus is one of the most important pathogens causing severe gastroenteritis in young children worldwide. In this paper, we describe a robust and simple reverse genetics system based on only rotavirus cDNAs and its application for engineering infectious recombinant rotaviruses harboring bioluminescent (NanoLuc) and fluorescent (EGFP and mCherry) protein genes. This highly efficient reverse genetics system and recombinant group A rotaviruses expressing reporters could be powerful tools for the study of different aspects of rotavirus replication. Furthermore, they may be useful for next-generation vaccine production for this medically important virus.

23 August 2014 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
GTGewen Tan
Gewen Tan
Hideki KasuyaHideki Kasuya
Hideki Kasuya
TSTevfik Tolga Sahin
Tevfik Tolga Sahin
KYKazuo Yamamura
Kazuo Yamamura
ZWZhiwen Wu
Zhiwen Wu
YKYasuhiro Kodera
Yasuhiro Kodera
Breast cancer is one of the most common and feared cancers faced by women. The prognosis of patients with advanced or recurrent breast cancer remains poor despite refinements in multimodality therapies involving chemotherapeutic and hormonal agents. Multimodal therapy with more specific and effective strategy is urgently needed. The oncolytic herpes simplex virus (HSV) has potential to become a new effective treatment option because of its broad host range and tumor selective viral distribution. Bevacizumab is a monoclonal antibody against VEGFA, which inhibits angiogenesis and therefore tumor growth. Our approach to enhance the antitumor effect of the oncolytic HSV is to combine oncolytic HSV HF10 and bevacizumab in the treatment of breast cancer. Our results showed that bevacizumab enhanced viral distribution as well as tumor hypoxia and expanded the population of apoptotic cells and therefore induced a synergistic antitumor effect. HF10 is expected to be a promising agent in combination with bevacizumab in the anticancer treatment.

15 April 2019 in Journal of Virology
Verified
Journal Article
Closed access
SKSatoshi Komoto
Satoshi Komoto
Saori FukudaSaori Fukuda
Saori Fukuda
MKMasanori Kugita
Masanori Kugita
RHRiona Hatazawa
Riona Hatazawa
CKChitose Koyama
Chitose Koyama
KTKoki Taniguchi
Koki Taniguchi
Human group A rotavirus (HuRVA) is a leading pathogen causing severe diarrhea in young children worldwide. In this paper, we describe the generation of recombinant HuRVA (strain KU) from only 11 cloned cDNAs encoding the HuRVA genome by reverse genetics. The growth properties of the recombinant HuRVA were similar to those of the parental RVA, providing a powerful tool for better understanding of HuRVA replication and pathogenesis. Furthermore, the ability to manipulate the genome of HuRVAs “to order” will be useful for next-generation vaccine production for this medically important virus and for the engineering of clinical vectors expressing any foreign genes.

1 November 2017 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
SKSatoshi Komoto
Satoshi Komoto
YKYuta Kanai
Yuta Kanai
Saori FukudaSaori Fukuda
Saori Fukuda
MKMasanori Kugita
Masanori Kugita
TKTakahiro Kawagishi
Takahiro Kawagishi
KTKoki Taniguchi
Koki Taniguchi
The use of overlapping open reading frames (ORFs) to synthesize more than one unique protein from a single mRNA has been described for several viruses. Segment 11 of the rotavirus genome encodes two nonstructural proteins, NSP5 and NSP6. The NSP6 ORF is present in the vast majority of rotavirus strains, and therefore the NSP6 protein would be expected to have a function in viral replication. However, there is no direct evidence of its function or requirement in the viral replication cycle yet. Here, taking advantage of a recently established plasmid-only-based reverse genetics system that allows rescue of recombinant rotaviruses entirely from cloned cDNAs, we generated NSP6-deficient viruses to directly address its significance in the viral replication cycle. Viable recombinant NSP6-deficient viruses could be engineered. Single-step growth curves and plaque formation of the NSP6-deficient viruses confirmed that NSP6 expression is of limited significance for RVA replication in cell culture, although the NSP6 protein seemed to promote efficient virus growth.IMPORTANCERotavirus is one of the most important pathogens of severe diarrhea in young children worldwide. The rotavirus genome, consisting of 11 segments of double-stranded RNA, encodes six structural proteins (VP1 to VP4, VP6, and VP7) and six nonstructural proteins (NSP1 to NSP6). Although specific functions have been ascribed to each of the 12 viral proteins, the role of NSP6 in the viral replication cycle remains unknown. In this study, we demonstrated that the NSP6 protein is not essential for viral replication in cell culture by using a recently developed plasmid-only-based reverse genetics system. This reverse genetics approach will be successfully applied to answer questions of great interest regarding the roles of rotaviral proteins in replication and pathogenicity, which can hardly be addressed by conventional approaches.

5 February 2018 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
SKSatoshi Komoto
Satoshi Komoto
TITomihiko Ide
Tomihiko Ide
MNManami Negoro
Manami Negoro
TTTakaaki Tanaka
Takaaki Tanaka
KAKazutoyo Asada
Kazutoyo Asada
KTKoki Taniguchi
Koki Taniguchi

9 September 2019 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
RTRatana Tacharoenmuang
Ratana Tacharoenmuang
SKSatoshi Komoto
Satoshi Komoto
RGRatigorn Guntapong
Ratigorn Guntapong
SUSompong Upachai
Sompong Upachai
PSPhakapun Singchai
Phakapun Singchai
TYTetsushi Yoshikawa
Tetsushi Yoshikawa